Atlas Trials

Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases

Clinical trial NCT03400839 · UNKNOWN

Trial details

NCT number
NCT03400839
Sponsor
Universidade Estadual de Londrina
Status
UNKNOWN
Study type
OBSERVATIONAL
Interstitial Lung Disease
Start date
2017-09-15
Primary completion
2023-10-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.